Therapeutic potential of targeting the complement cascade in critical care medicine
Caring for the critical care patient involves many different areas of clinical expertise and serves a diverse patient population. Novel therapeutics for the critically ill must be approached with caution, because the underlying molecular mechanisms of the disease process for several commonly seen ty...
Gespeichert in:
| Veröffentlicht in: | Critical care medicine 2003-01, Vol.31 (1 Suppl), p.S97-S104 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | S104 |
|---|---|
| container_issue | 1 Suppl |
| container_start_page | S97 |
| container_title | Critical care medicine |
| container_volume | 31 |
| creator | Bhole, Deepak Stahl, Gregory L |
| description | Caring for the critical care patient involves many different areas of clinical expertise and serves a diverse patient population. Novel therapeutics for the critically ill must be approached with caution, because the underlying molecular mechanisms of the disease process for several commonly seen types of patients (i.e., sepsis, shock, ischemia/reperfusion) are not fully understood. A potentially new and advancing area of therapeutics that may hold promise for the critically ill is inhibition of the complement system. Various novel complement inhibitors are being developed and several are in clinical trials. The advancement of this novel area of therapeutics may one day aid the clinician by providing several different complement inhibitors/antagonists for controlling complement activation or its biologically active mediators. |
| doi_str_mv | 10.1097/00003246-200301001-00014 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72978535</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72978535</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4224-3a14db7e8c612745d94773a17de2285bbd534b0c3c1b0063bac0c91ccd9384f43</originalsourceid><addsrcrecordid>eNp1kclOBCEQhonR6Li8guHkrZWth-ZojFti4kE9E7q6ZgbtTaBjfHsZZ9STXCqp-n4IXxFCOTvnzOgLlo8Ual6IXBlnjBe5w9UOmfFSsoIJI3fJjDHDCqmMPCCHMb6uiVLLfXLARamUqeSMPD2vMLgRp-SBjkPCPnnX0mFBkwtLTL5f0rRCCkM3ttjlMQUXwTVIfU8h-JzLPLiAtMPGg-_xmOwtXBvxZFuPyMvN9fPVXfHweHt_dflQgBJCFdJx1dQaK5hzoVXZGKV1buoGhajKum5KqWoGEnjN2FzWDhgYDtAYWamFkkfkbHPvGIb3CWOynY-Abet6HKZotTC6KmWZwWoDQhhiDLiwY_CdC5-WM7sWan-E2l-h9ltojp5u35jq_L-_4NZgBtQG-BjahCG-tdMHBrtC16aV_W9R8guUMoA_</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72978535</pqid></control><display><type>article</type><title>Therapeutic potential of targeting the complement cascade in critical care medicine</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Bhole, Deepak ; Stahl, Gregory L</creator><creatorcontrib>Bhole, Deepak ; Stahl, Gregory L</creatorcontrib><description>Caring for the critical care patient involves many different areas of clinical expertise and serves a diverse patient population. Novel therapeutics for the critically ill must be approached with caution, because the underlying molecular mechanisms of the disease process for several commonly seen types of patients (i.e., sepsis, shock, ischemia/reperfusion) are not fully understood. A potentially new and advancing area of therapeutics that may hold promise for the critically ill is inhibition of the complement system. Various novel complement inhibitors are being developed and several are in clinical trials. The advancement of this novel area of therapeutics may one day aid the clinician by providing several different complement inhibitors/antagonists for controlling complement activation or its biologically active mediators.</description><identifier>ISSN: 0090-3493</identifier><identifier>EISSN: 1530-0293</identifier><identifier>DOI: 10.1097/00003246-200301001-00014</identifier><identifier>PMID: 12544983</identifier><language>eng</language><publisher>United States: by the Society of Critical Care Medicine and Lippincott Williams & Wilkins</publisher><subject>Complement Inactivator Proteins - therapeutic use ; Critical Care - methods ; Drug Delivery Systems ; Humans ; Immune System - drug effects ; Immune System - immunology ; Inflammation - drug therapy ; Inflammation - immunology ; Sepsis - drug therapy ; Sepsis - immunology ; Shock - drug therapy ; Shock - immunology</subject><ispartof>Critical care medicine, 2003-01, Vol.31 (1 Suppl), p.S97-S104</ispartof><rights>2003 by the Society of Critical Care Medicine and Lippincott Williams & Wilkins</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4224-3a14db7e8c612745d94773a17de2285bbd534b0c3c1b0063bac0c91ccd9384f43</citedby><cites>FETCH-LOGICAL-c4224-3a14db7e8c612745d94773a17de2285bbd534b0c3c1b0063bac0c91ccd9384f43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12544983$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bhole, Deepak</creatorcontrib><creatorcontrib>Stahl, Gregory L</creatorcontrib><title>Therapeutic potential of targeting the complement cascade in critical care medicine</title><title>Critical care medicine</title><addtitle>Crit Care Med</addtitle><description>Caring for the critical care patient involves many different areas of clinical expertise and serves a diverse patient population. Novel therapeutics for the critically ill must be approached with caution, because the underlying molecular mechanisms of the disease process for several commonly seen types of patients (i.e., sepsis, shock, ischemia/reperfusion) are not fully understood. A potentially new and advancing area of therapeutics that may hold promise for the critically ill is inhibition of the complement system. Various novel complement inhibitors are being developed and several are in clinical trials. The advancement of this novel area of therapeutics may one day aid the clinician by providing several different complement inhibitors/antagonists for controlling complement activation or its biologically active mediators.</description><subject>Complement Inactivator Proteins - therapeutic use</subject><subject>Critical Care - methods</subject><subject>Drug Delivery Systems</subject><subject>Humans</subject><subject>Immune System - drug effects</subject><subject>Immune System - immunology</subject><subject>Inflammation - drug therapy</subject><subject>Inflammation - immunology</subject><subject>Sepsis - drug therapy</subject><subject>Sepsis - immunology</subject><subject>Shock - drug therapy</subject><subject>Shock - immunology</subject><issn>0090-3493</issn><issn>1530-0293</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kclOBCEQhonR6Li8guHkrZWth-ZojFti4kE9E7q6ZgbtTaBjfHsZZ9STXCqp-n4IXxFCOTvnzOgLlo8Ual6IXBlnjBe5w9UOmfFSsoIJI3fJjDHDCqmMPCCHMb6uiVLLfXLARamUqeSMPD2vMLgRp-SBjkPCPnnX0mFBkwtLTL5f0rRCCkM3ttjlMQUXwTVIfU8h-JzLPLiAtMPGg-_xmOwtXBvxZFuPyMvN9fPVXfHweHt_dflQgBJCFdJx1dQaK5hzoVXZGKV1buoGhajKum5KqWoGEnjN2FzWDhgYDtAYWamFkkfkbHPvGIb3CWOynY-Abet6HKZotTC6KmWZwWoDQhhiDLiwY_CdC5-WM7sWan-E2l-h9ltojp5u35jq_L-_4NZgBtQG-BjahCG-tdMHBrtC16aV_W9R8guUMoA_</recordid><startdate>200301</startdate><enddate>200301</enddate><creator>Bhole, Deepak</creator><creator>Stahl, Gregory L</creator><general>by the Society of Critical Care Medicine and Lippincott Williams & Wilkins</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200301</creationdate><title>Therapeutic potential of targeting the complement cascade in critical care medicine</title><author>Bhole, Deepak ; Stahl, Gregory L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4224-3a14db7e8c612745d94773a17de2285bbd534b0c3c1b0063bac0c91ccd9384f43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Complement Inactivator Proteins - therapeutic use</topic><topic>Critical Care - methods</topic><topic>Drug Delivery Systems</topic><topic>Humans</topic><topic>Immune System - drug effects</topic><topic>Immune System - immunology</topic><topic>Inflammation - drug therapy</topic><topic>Inflammation - immunology</topic><topic>Sepsis - drug therapy</topic><topic>Sepsis - immunology</topic><topic>Shock - drug therapy</topic><topic>Shock - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bhole, Deepak</creatorcontrib><creatorcontrib>Stahl, Gregory L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bhole, Deepak</au><au>Stahl, Gregory L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Therapeutic potential of targeting the complement cascade in critical care medicine</atitle><jtitle>Critical care medicine</jtitle><addtitle>Crit Care Med</addtitle><date>2003-01</date><risdate>2003</risdate><volume>31</volume><issue>1 Suppl</issue><spage>S97</spage><epage>S104</epage><pages>S97-S104</pages><issn>0090-3493</issn><eissn>1530-0293</eissn><abstract>Caring for the critical care patient involves many different areas of clinical expertise and serves a diverse patient population. Novel therapeutics for the critically ill must be approached with caution, because the underlying molecular mechanisms of the disease process for several commonly seen types of patients (i.e., sepsis, shock, ischemia/reperfusion) are not fully understood. A potentially new and advancing area of therapeutics that may hold promise for the critically ill is inhibition of the complement system. Various novel complement inhibitors are being developed and several are in clinical trials. The advancement of this novel area of therapeutics may one day aid the clinician by providing several different complement inhibitors/antagonists for controlling complement activation or its biologically active mediators.</abstract><cop>United States</cop><pub>by the Society of Critical Care Medicine and Lippincott Williams & Wilkins</pub><pmid>12544983</pmid><doi>10.1097/00003246-200301001-00014</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0090-3493 |
| ispartof | Critical care medicine, 2003-01, Vol.31 (1 Suppl), p.S97-S104 |
| issn | 0090-3493 1530-0293 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_72978535 |
| source | MEDLINE; Journals@Ovid Complete |
| subjects | Complement Inactivator Proteins - therapeutic use Critical Care - methods Drug Delivery Systems Humans Immune System - drug effects Immune System - immunology Inflammation - drug therapy Inflammation - immunology Sepsis - drug therapy Sepsis - immunology Shock - drug therapy Shock - immunology |
| title | Therapeutic potential of targeting the complement cascade in critical care medicine |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T06%3A33%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Therapeutic%20potential%20of%20targeting%20the%20complement%20cascade%20in%20critical%20care%20medicine&rft.jtitle=Critical%20care%20medicine&rft.au=Bhole,%20Deepak&rft.date=2003-01&rft.volume=31&rft.issue=1%20Suppl&rft.spage=S97&rft.epage=S104&rft.pages=S97-S104&rft.issn=0090-3493&rft.eissn=1530-0293&rft_id=info:doi/10.1097/00003246-200301001-00014&rft_dat=%3Cproquest_cross%3E72978535%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72978535&rft_id=info:pmid/12544983&rfr_iscdi=true |